FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s lisdexamfetamine dimesylate as a generic version of the ADHD and binge eating disorder medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)